🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS · Delayed Price · Currency is USD
0.32472
+0.00082 (0.25%)
At close: Nov 20, 2026

Elite Pharmaceuticals Income Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
144.77148.8784.0456.6334.1632.26
Revenue Growth
17.80%77.13%48.42%65.79%5.87%27.11%
Cost of Revenue
81.5573.8543.9630.2717.5617.47
Gross Profit
63.2275.0240.0926.3616.5914.8
Selling, General & Admin
17.517.697.155.124.46
Research & Development
6.595.747.966.886.24.05
Operating Expenses
25.7225.0618.8815.5712.639.72
Operating Income
37.549.9621.210.793.975.07
Interest Expense
-0.3-0.4-0.77-0.59-1.11-0.19
Interest & Investment Income
0.580.210.020.020.010
Other Non Operating Income (Expenses)
32.217.89-18.9-11.520.421.43
EBT Excluding Unusual Items
7057.661.55-1.33.286.3
Gain (Loss) on Sale of Assets
----1-
Asset Writedown
-0.85-0.85-1.6--0.29-
Other Unusual Items
---1.76-0.86
Pretax Income
69.1556.81-0.050.463.997.16
Income Tax Expense
8.8611.944.26-19.650.42-1.74
Net Income
60.2844.87-4.3120.113.568.9
Net Income to Common
60.2844.87-4.3120.113.568.9
Net Income Growth
332.97%--464.56%-59.97%74.87%
Shares Outstanding (Basic)
1,0761,0731,0681,0151,0131,011
Shares Outstanding (Diluted)
1,1611,1381,0681,0231,0131,011
Shares Change
7.95%6.56%4.40%1.02%0.23%7.17%
EPS (Basic)
0.060.04-0.000.020.000.01
EPS (Diluted)
0.030.03-0.000.020.000.01
EPS Growth
128.93%--537.54%-57.99%81.05%

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
8.7222.825.83-4.04-2.46.01
Free Cash Flow Per Share
0.010.020.01-0.00-0.000.01
Gross Margin
43.67%50.40%47.70%46.55%48.58%45.86%
Operating Margin
25.90%33.56%25.23%19.05%11.62%15.72%
Profit Margin
41.64%30.14%-5.13%35.51%10.43%27.58%
Free Cash Flow Margin
6.02%15.33%6.94%-7.14%-7.02%18.63%
EBITDA
39.0151.5122.8912.165.236.27
EBITDA Margin
26.95%34.60%27.24%21.47%15.32%19.42%
D&A For EBITDA
1.511.551.691.371.261.19
EBIT
37.549.9621.210.793.975.07
EBIT Margin
25.90%33.56%25.23%19.05%11.62%15.72%
Effective Tax Rate
12.82%21.02%--10.64%-
Revenue as Reported
148.87148.8784.0456.6334.1632.26